Display options
Cite
Chen X, Barclay JW, Burgoyne RD, et al. Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases. Chem Cent J. 2015;9:65doi: 10.1186/s13065-015-0143-y.
Chen, X., Barclay, J. W., Burgoyne, R. D., & Morgan, A. (2015). Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases. Chemistry Central journal, 965. https://doi.org/10.1186/s13065-015-0143-y
Chen, Xi, et al. "Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases." Chemistry Central journal vol. 9 (2015): 65. doi: https://doi.org/10.1186/s13065-015-0143-y
Chen X, Barclay JW, Burgoyne RD, Morgan A. Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases. Chem Cent J. 2015 Nov 26;9:65. doi: 10.1186/s13065-015-0143-y. eCollection 2015. PMID: 26617668; PMCID: PMC4661952.
Copy Download .nbib Format: NLM
Share it on

Chem Cent J. 2015 Nov 26;9:65. doi: 10.1186/s13065-015-0143-y. eCollection 2015.

Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases.

Chemistry Central journal

Xi Chen, Jeff W Barclay, Robert D Burgoyne, Alan Morgan

Affiliations

  1. Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Crown St, Liverpool, L69 3BX UK ; Centre for Neurodegenerative Science, Van Andel Research Institute, 333 Bostwick Avenue NE, Grand Rapids, Michigan, MI 49503 USA.
  2. Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Crown St, Liverpool, L69 3BX UK.

PMID: 26617668 PMCID: PMC4661952 DOI: 10.1186/s13065-015-0143-y

Abstract

Age-associated neurodegenerative disorders such as Alzheimer's disease are a major public health challenge, due to the demographic increase in the proportion of older individuals in society. However, the relatively few currently approved drugs for these conditions provide only symptomatic relief. A major goal of neurodegeneration research is therefore to identify potential new therapeutic compounds that can slow or even reverse disease progression, either by impacting directly on the neurodegenerative process or by activating endogenous physiological neuroprotective mechanisms that decline with ageing. This requires model systems that can recapitulate key features of human neurodegenerative diseases that are also amenable to compound screening approaches. Mammalian models are very powerful, but are prohibitively expensive for high-throughput drug screens. Given the highly conserved neurological pathways between mammals and invertebrates, Caenorhabditis elegans has emerged as a powerful tool for neuroprotective compound screening. Here we describe how C. elegans has been used to model various human ageing-associated neurodegenerative diseases and provide an extensive list of compounds that have therapeutic activity in these worm models and so may have translational potential.

Keywords: Adult onset neuronal ceroid lipofuscinosis; Aging; Alzheimer’s disease; Amyotrophic lateral sclerosis; Caenorhabditis elegans; Compound screening; Frontotemporal dementia; Huntington’s disease; Neurodegeneration; Parkinson’s disease

References

  1. EMBO Mol Med. 2009 Nov;1(8-9):360-70 - PubMed
  2. J Neurochem. 1998 Oct;71(4):1616-25 - PubMed
  3. PLoS One. 2009 Oct 06;4(10 ):e7227 - PubMed
  4. Hum Mol Genet. 2001 Sep 15;10 (19):2013-23 - PubMed
  5. Science. 2011 Dec 2;334(6060):1241-5 - PubMed
  6. Arch Neurol. 2008 Feb;65(2):184-9 - PubMed
  7. Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9980-5 - PubMed
  8. PLoS One. 2011;6(11):e26741 - PubMed
  9. J Alzheimers Dis. 2003 Aug;5(4):287-300 - PubMed
  10. J Neurosci. 2010 Dec 1;30(48):16208-19 - PubMed
  11. Neurobiol Dis. 2010 Nov;40(2):424-31 - PubMed
  12. Science. 2013 Mar 8;339(6124):1216-9 - PubMed
  13. Neurodegener Dis. 2004;1(4-5):175-83 - PubMed
  14. Mol Neurodegener. 2015 Sep 29;10:51 - PubMed
  15. Genetics. 2010 Nov;186(3):857-66 - PubMed
  16. Mech Ageing Dev. 2010 Apr;131(4):261-9 - PubMed
  17. Hum Mol Genet. 2011 May 15;20(10):1952-65 - PubMed
  18. Ann Neurol. 2013 Jul;74(1):39-52 - PubMed
  19. Prog Mol Biol Transl Sci. 2011;100:499-514 - PubMed
  20. Nat Chem Biol. 2010 Jul;6(7):549-57 - PubMed
  21. Semin Cell Dev Biol. 2015 Apr;40:153-9 - PubMed
  22. Cell. 2012 Feb 3;148(3):421-33 - PubMed
  23. J Neurochem. 2003 Jul;86(1):165-72 - PubMed
  24. PLoS One. 2012;7(8):e43990 - PubMed
  25. Proc Natl Acad Sci U S A. 2007 Feb 6;104(6):1971-6 - PubMed
  26. Neurosci Lett. 2008 Jul 11;439(2):129-33 - PubMed
  27. Phytomedicine. 2010 Sep;17 (11):902-9 - PubMed
  28. EMBO J. 2009 Oct 21;28(20):3256-68 - PubMed
  29. Antioxid Redox Signal. 2013 Feb 10;18(5):481-90 - PubMed
  30. Immunology. 2010 Feb;129(2):154-69 - PubMed
  31. J Neurosci. 2012 Jul 25;32(30):10156-69 - PubMed
  32. JAMA. 2005 Oct 19;294(15):1934-43 - PubMed
  33. Neurochem Res. 2012 Jan;37(1):40-8 - PubMed
  34. Nature. 2000 Jul 20;406(6793):306-9 - PubMed
  35. Semin Cell Dev Biol. 2015 Apr;40:106-14 - PubMed
  36. PLoS One. 2013;8(3):e58893 - PubMed
  37. Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):728-33 - PubMed
  38. J Biol Chem. 2011 May 27;286(21):18784-94 - PubMed
  39. Methods Enzymol. 2006;412:256-82 - PubMed
  40. Aging Cell. 2011 Jun;10(3):506-19 - PubMed
  41. Biol Psychiatry. 2013 Mar 1;73(5):464-71 - PubMed
  42. Hum Mol Genet. 2010 Aug 15;19(16):3206-18 - PubMed
  43. Hum Mol Genet. 2014 Nov 15;23(22):5916-27 - PubMed
  44. PLoS Genet. 2008 Mar 21;4(3):e1000027 - PubMed
  45. BMC Genomics. 2012 Feb 14;13:71 - PubMed
  46. PLoS Genet. 2009 Mar;5(3):e1000399 - PubMed
  47. Exp Gerontol. 2006 Oct;41(10):1007-13 - PubMed
  48. J Biol Chem. 2009 Jun 12;284(24):16482-91 - PubMed
  49. BMC Genomics. 2012 Mar 13;13:91 - PubMed
  50. Neurobiol Dis. 2005 Nov;20(2):372-83 - PubMed
  51. Acta Pharmacol Sin. 2013 May;34(5):644-50 - PubMed
  52. Hum Mol Genet. 2005 Nov 15;14 (22):3407-23 - PubMed
  53. Epilepsy Curr. 2002 Mar;2(2):53-56 - PubMed
  54. Development. 1998 Sep;125(18):3599-606 - PubMed
  55. J Alzheimers Dis. 2010;19(2):681-90 - PubMed
  56. Neuron. 2002 Jul 3;35(1):9-12 - PubMed
  57. Mar Drugs. 2015 Apr 14;13(4):2250-66 - PubMed
  58. Proc Natl Acad Sci U S A. 2007 Sep 4;104(36):14525-30 - PubMed
  59. Nature. 2011 Apr 14;472(7342):226-9 - PubMed
  60. Hum Mol Genet. 2009 Jan 1;18(1):97-104 - PubMed
  61. Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17131-6 - PubMed
  62. Clin Exp Immunol. 2008 May;152(2):201-10 - PubMed
  63. Biochim Biophys Acta. 2013 Nov;1832(11):1795-800 - PubMed
  64. PLoS One. 2014 Jan 08;9(1):e85305 - PubMed
  65. Curr Alzheimer Res. 2011 Aug;8(5):563-72 - PubMed
  66. J Biol Chem. 2015 Nov 20;290(47):28540-58 - PubMed
  67. Neuropharmacology. 2014 Jul;82:108-20 - PubMed
  68. Cell Cycle. 2014;13(24):3903-8 - PubMed
  69. Autophagy. 2007 Nov-Dec;3(6):569-80 - PubMed
  70. PLoS One. 2012;7(7):e42117 - PubMed
  71. Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4013-8 - PubMed
  72. PLoS One. 2014 May 09;9(5):e96835 - PubMed
  73. Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9368-72 - PubMed
  74. J Biol Chem. 2005 Dec 30;280(52):42655-68 - PubMed
  75. J Neuropathol Exp Neurol. 2003 Jan;62(1):1-13 - PubMed
  76. G3 (Bethesda). 2012 Aug;2(8):961-75 - PubMed
  77. Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10417-22 - PubMed
  78. Parkinsonism Relat Disord. 2001 Jul;7(3):185-191 - PubMed
  79. J Biomol Screen. 2013 Dec;18(10):1186-92 - PubMed
  80. Sci Rep. 2015 Sep 23;5:14392 - PubMed
  81. Neurosci Lett. 1999 Mar 19;263(1):17-20 - PubMed
  82. Nat Rev Drug Discov. 2011 Oct 21;10(11):853-67 - PubMed
  83. J Biol Chem. 2009 Dec 18;284(51):35758-68 - PubMed
  84. Science. 2005 Jan 14;307(5707):258-62 - PubMed
  85. Neurobiol Aging. 2001 Mar-Apr;22(2):217-26 - PubMed
  86. Trends Cell Biol. 1998 Nov;8(11):425-7 - PubMed
  87. Neurosci Lett. 2013 Apr 29;541:116-9 - PubMed
  88. Oxid Med Cell Longev. 2015;2015:740162 - PubMed
  89. Neurobiol Aging. 2003 May-Jun;24(3):397-413 - PubMed
  90. Neurobiol Dis. 2010 Oct;40(1):73-81 - PubMed
  91. Exp Gerontol. 2009 Jun-Jul;44(6-7):462-6 - PubMed
  92. Prion. 2011 Jan-Mar;5(1):28-38 - PubMed
  93. J Neurosci. 2006 Dec 13;26(50):13102-13 - PubMed
  94. J Neurosci. 2009 Jul 22;29(29):9210-8 - PubMed
  95. BMC Neurosci. 2005 Aug 25;6:54 - PubMed
  96. PLoS One. 2011;6(12 ):e28835 - PubMed
  97. Genetics. 2013 Nov;195(3):635-42 - PubMed
  98. J Ethnopharmacol. 2012 May 7;141(1):41-7 - PubMed
  99. Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13318-23 - PubMed
  100. Neurochem Int. 2009 Feb;54(2):111-8 - PubMed
  101. PLoS Genet. 2013 Mar;9(3):e1003351 - PubMed
  102. Planta Med. 2009 Feb;75(3):216-21 - PubMed
  103. Neurobiol Dis. 2010 Feb;37(2):330-8 - PubMed
  104. Hum Mol Genet. 2011 Aug 1;20(15):2996-3009 - PubMed
  105. Cell. 2013 Mar 28;153(1):228-39 - PubMed
  106. Hum Mol Genet. 2013 Jan 15;22(2):328-44 - PubMed
  107. Proc Natl Acad Sci U S A. 2000 May 23;97(11):5750-5 - PubMed
  108. PLoS One. 2012;7(1):e29729 - PubMed
  109. J Mol Neurosci. 2007;31(2):127-37 - PubMed
  110. PLoS One. 2011;6(11):e27762 - PubMed
  111. Neurobiol Aging. 2013 Sep;34(9):2175-82 - PubMed
  112. Mol Neurodegener. 2012 Nov 21;7:57 - PubMed
  113. Nat Genet. 2005 Apr;37(4):349-50 - PubMed
  114. Cell Calcium. 2012 Sep-Oct;52(3-4):289-95 - PubMed
  115. Science. 2002 Jun 14;296(5575):1991-5 - PubMed
  116. Hum Mol Genet. 2008 Oct 1;17(19):2997-3009 - PubMed
  117. Molecules. 2014 Jun 10;19(6):7757-69 - PubMed
  118. J Neurosci. 2010 Apr 14;30(15):5394-403 - PubMed
  119. Am J Hum Genet. 2011 Aug 12;89(2):241-52 - PubMed
  120. Hum Mol Genet. 2012 Aug 15;21(16):3587-603 - PubMed
  121. J Biol Chem. 2012 Mar 2;287(10):7098-109 - PubMed
  122. Hum Mol Genet. 2008 May 15;17 (10 ):1373-85 - PubMed
  123. PLoS One. 2013 Jun 10;8(6):e64953 - PubMed
  124. J Biol Chem. 2006 Jan 6;281(1):334-40 - PubMed
  125. Neurobiol Aging. 2003 May-Jun;24(3):415-20 - PubMed
  126. Hum Mol Genet. 2011 Oct 15;20(20):3933-42 - PubMed
  127. J Struct Biol. 2004 Apr-May;146(1-2):242-50 - PubMed
  128. J Biol Chem. 2012 Feb 3;287(6):4107-20 - PubMed
  129. J Neurosci. 2005 Apr 13;25(15):3801-12 - PubMed
  130. Nat Rev Drug Discov. 2011 Jun 24;10 (7):507-19 - PubMed
  131. Neurobiol Aging. 2009 Jan;30(1):22-33 - PubMed
  132. PLoS One. 2007 Jun 06;2(6):e504 - PubMed
  133. Hum Mol Genet. 2006 Mar 15;15(6):1025-41 - PubMed
  134. PLoS Genet. 2009 Jan;5(1):e1000350 - PubMed
  135. Clin Genet. 2013 Jun;83(6):571-5 - PubMed
  136. Arthritis Rheum. 2002 Dec;46(12):3273-82 - PubMed
  137. Hum Mol Genet. 2011 Jan 15;20(2):245-60 - PubMed
  138. Neuropharmacology. 2010 Sep-Oct;59(4-5):358-65 - PubMed
  139. Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13091-6 - PubMed

Publication Types